Inventor
JONES KYLE S
US14 patents
⚠️ This page may combine multiple inventors who share the name “JONES KYLE S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INHIBRX INC
9 patentsUS10501551B2Dec 10, 2019
Multivalent and multispecific 41BB-binding fusion proteins
INHIBRX INC7 citations80
US10308720B2Jun 4, 2019
Multivalent and multispecific DR5-binding fusion proteins
INHIBRX INC3 citations71
US10093742B2Oct 9, 2018
Multispecific GITR-binding fusion proteins and methods of use thereof
INHIBRX INC4 citations71
US11560428B2Jan 24, 2023
CD33-binding polypeptides and uses thereof
INHIBRX INC2 citations69
US11117972B2Sep 14, 2021
Multivalent and multispecific OX40-binding fusion proteins
INHIBRX INC2 citations69
US11976126B2May 7, 2024
Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells
INHIBRX INC0 citations61
US11117973B2Sep 14, 2021
Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms
INHIBRX INC0 citations61
US11566078B2Jan 31, 2023
PDL1-binding proteins
INHIBRX INC0 citations59
US10844129B2Nov 24, 2020
Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids
INHIBRX INC0 citations50
INHIBRX BIOSCIENCES INC
4 patentsUS12227584B2Feb 18, 2025
Multivalent and multispecific OX40-binding fusion proteins
INHIBRX BIOSCIENCES INC0 citations59
US12187804B2Jan 7, 2025
Multivalent and multispecific 41BB-binding proteins
INHIBRX BIOSCIENCES INC0 citations59
US12084502B2Sep 10, 2024
CD33-binding polypeptides and uses thereof
INHIBRX BIOSCIENCES INC0 citations58
US12195533B2Jan 14, 2025
Multispecific polypeptide constructs containing a constrained CD3 binding domain and a receptor binding region and methods of using the same
INHIBRX BIOSCIENCES INC0 citations49